TrialPanorama/TrialPanorama-database huggingface dataset:
Study 22050040 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 20738023 — Surrogate Endpoint (SUR): Blood pressure
Study 10220833 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 10220833 — Surrogate Endpoint (SUR): Bone mineral density
Study 12675 — Surrogate Endpoint (SUR): Blood pressure
Study 29237134 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 27732968 — Predictive Biomarker (PRD): SBF2 mRNA
Genes: SBF2; CMT4B2; KIAA1766; MTMR13
Study 22816732 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 22816732 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22816732 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9086386 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9086386 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 18640939 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 24081232 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study 3046791 — Surrogate Endpoint (SUR): Blood pressure
Study 25843292 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10823386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10823386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10823386 — Safety Biomarker (SAF): IL-6 and IL-10
Study 26122803 — Surrogate Endpoint (SUR): Blood pressure
Study 16138585 — Surrogate Endpoint (SUR): Sperm parameters
Study 19744828 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 16182105 — Surrogate Endpoint (SUR): Blood pressure
Study 7517172 — Surrogate Endpoint (SUR): Serum creatinine
Study 30536191 — Monitoring Biomarker (MOI): Procalcitonin
Study 25749297 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 12584283 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 26848117 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 9735502 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7523961 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29940335 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 27065472 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 27065472 — Safety Biomarker (SAF): BDNF
Study 23511562 — Predictive Biomarker (PRD): Hormone receptor
Study 27305952 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 11152917 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11152917 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16213287 — Surrogate Endpoint (SUR): Serum creatinine
Study 10075386 — Surrogate Endpoint (SUR): Blood pressure
Study 30019072 — Predictive Biomarker (PRD): SBSN mRNA
Genes: SBSN; UNQ698/PRO1343
Study 11300658 — Surrogate Endpoint (SUR): Blood pressure
Study 2688507 — Surrogate Endpoint (SUR): Blood pressure
Study 31490376 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 23768736 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 20166337 — Surrogate Endpoint (SUR): Blood pressure
Study 20166337 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29229363 — Surrogate Endpoint (SUR): Blood pressure
Study 29229363 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26945711 — Surrogate Endpoint (SUR): Bone mineral density
Study 15875094 — Surrogate Endpoint (SUR): Bone mineral density
Study 12867219 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12867219 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 11955025 — Surrogate Endpoint (SUR): Blood pressure
Study 11955025 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11955025 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24135218 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24135218 — Surrogate Endpoint (SUR): Serum creatinine
Study 21438793 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 21438793 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21438793 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21438793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9678089 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 9678089 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 31577697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26112886 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 26112886 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10672134 — Surrogate Endpoint (SUR): Serum creatinine
Study 8410923 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17971530 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 22364262 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 22364262 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study 17442512 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 18068613 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15168319 — Safety Biomarker (SAF): Reactive oxygen species
Study 15168319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15168319 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 15168319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 15168319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29682995 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 29682995 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26972635 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26972635 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26972635 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30665814 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 8150641 — Surrogate Endpoint (SUR): Blood pressure
Study 2834976 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 2834976 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15590442 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 11185637 — Surrogate Endpoint (SUR): Blood pressure
Study 3887159 — Surrogate Endpoint (SUR): Blood pressure
Study 29628593 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29628593 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 29628593 — Surrogate Endpoint (SUR): Blood pressure
Study 26661403 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 26661403 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16137355 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 10803490 — Surrogate Endpoint (SUR): Blood pressure
Study 31048181 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 26062689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26062689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22248554 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22248554 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19704107 — Surrogate Endpoint (SUR): Blood pressure
Study 16717477 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 16717477 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 7995007 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7995007 — Surrogate Endpoint (SUR): Blood pressure
Study 24433434 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 19539427 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 8887822 — Surrogate Endpoint (SUR): Blood pressure
Study 31571412 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 21831714 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15070938 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 11317472 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11317472 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2967183 — Surrogate Endpoint (SUR): Blood pressure
Study 30380020 — Predictive Biomarker (PRD): HBEGF mRNA
Genes: HBEGF; DTR; DTS; HEGFL
Study 21481280 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 21491487 — Surrogate Endpoint (SUR): Bone mineral density
Study 21491487 — Surrogate Endpoint (SUR): Serum calcium
Study 2967304 — Surrogate Endpoint (SUR): Blood pressure
Study 12655529 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 25518574 — Surrogate Endpoint (SUR): Blood pressure
Study 28651697 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study 21863028 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 1300436 — Surrogate Endpoint (SUR): Serum creatinine
Study 31756267 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 29704641 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29704641 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 27273977 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 24166468 — Surrogate Endpoint (SUR): Blood pressure
Study 30668423 — Surrogate Endpoint (SUR): Blood pressure
Study 30668423 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26790200 — Surrogate Endpoint (SUR): Blood pressure
Study 23125396 — Predictive Biomarker (PRD): MCCC2 mRNA
Genes: MCCC2; MCCB
Study 1706012 — Surrogate Endpoint (SUR): Blood pressure
Study 26044067 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 26044067 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 26044067 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 24124717 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 19616720 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15364766 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 8076657 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21808851 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 2686485 — Surrogate Endpoint (SUR): Blood pressure
Study 31960497 — Predictive Biomarker (PRD): IL1R2 mRNA
Genes: IL1R2; IL1RB
Study 31960497 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A2 mRNA
Genes: SRD5A2
Study 30037019 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30037019 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15816586 — Surrogate Endpoint (SUR): Blood pressure
Study 9714526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21851202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 19469885 — Surrogate Endpoint (SUR): Bone mineral density
Study 15521232 — Surrogate Endpoint (SUR): Blood pressure
Study 23804232 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 23804232 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 8748408 — Surrogate Endpoint (SUR): Serum creatinine
Study 30571235 — Surrogate Endpoint (SUR): Serum creatinine
Study 24368552 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 9860107 — Surrogate Endpoint (SUR): Blood pressure
Study 26188167 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 26188167 — Pharmacodynamic Biomarker (PDY): Auditory mismatch negativity
Study 14677616 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 3068344 — Surrogate Endpoint (SUR): Blood pressure
Study 3068344 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19564636 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 28841229 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26983946 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 21876511 — Surrogate Endpoint (SUR): Blood pressure
Study 25416514 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 8729587 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 8729587 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8729587 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7049710 — Surrogate Endpoint (SUR): Blood pressure
Study 28814161 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16306499 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 11887180 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 30585337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30585337 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 19379588 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 17321919 — Surrogate Endpoint (SUR): Blood pressure
Study 7802307 — Surrogate Endpoint (SUR): Blood pressure
Study 24548259 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study 23706327 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21718836 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 21718836 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 21718836 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 21718836 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19938555 — Surrogate Endpoint (SUR): Serum creatinine
Study 11669215 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22595313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22595313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30485425 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 30485425 — Predictive Biomarker (PRD): CSAG3 mRNA
Genes: CSAG2; TRAG3; CSAG3; CSAG3A
Study 30485425 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 28260986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 25757593 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25757593 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19699472 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 9647058 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 19150495 — Safety Biomarker (SAF): IL-6 and IL-10
Study 18772509 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18772509 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18772509 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 15970103 — Surrogate Endpoint (SUR): Blood pressure
Study 12575474 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 10597810 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23441978 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 23441978 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 23441978 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 25271627 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23103475 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23103475 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 23103475 — Surrogate Endpoint (SUR): Blood pressure
Study 16647616 — Surrogate Endpoint (SUR): Blood pressure
Study 8667466 — Surrogate Endpoint (SUR): Blood pressure
Study 31420191 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 24084496 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 24084496 — Predictive Biomarker (PRD): HTRA1 mRNA
Genes: HTRA1; HTRA; PRSS11
Study 24084496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 24084496 — Predictive Biomarker (PRD): TLR3 mRNA
Genes: TLR3
Study 24084496 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 9870876 — Safety Biomarker (SAF): Interleukin 1
Study 9870876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 2659737 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 2659737 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 29895931 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 29895931 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 22418981 — Surrogate Endpoint (SUR): Serum sodium
Study 22418981 — Surrogate Endpoint (SUR): Blood pressure
Study 20724934 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15309331 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 8531615 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 1693733 — Surrogate Endpoint (SUR): Blood pressure
Study 24124672 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 17518172 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17518172 — Safety Biomarker (SAF): IL-6 and IL-10
Study 17989696 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 1901104 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 24423077 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 24423077 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 24423077 — Surrogate Endpoint (SUR): Serum creatinine
Study 11591185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 3346988 — Surrogate Endpoint (SUR): Blood pressure
Study 31867713 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study 26093975 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31549494 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 25539696 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 25539696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25539696 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25539696 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 25539696 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22686292 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21654733 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study 30170329 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 26931509 — Surrogate Endpoint (SUR): Blood pressure
Study 1353708 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1353708 — Surrogate Endpoint (SUR): Blood pressure
Study 24564252 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 24564252 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 23253713 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 9700879 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23574808 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 9064945 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1591513 — Surrogate Endpoint (SUR): Blood pressure
Study 26699666 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 23406672 — Surrogate Endpoint (SUR): Blood pressure
Study 21836046 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 17309402 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15121405 — Surrogate Endpoint (SUR): Bone mineral density
Study 8017643 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 8017643 — Surrogate Endpoint (SUR): Blood pressure
Study 2806735 — Surrogate Endpoint (SUR): Forced vital capacity
Study 24043732 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 19352043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10072831 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 10072831 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 7691117 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 25394692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25394692 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25394692 — Surrogate Endpoint (SUR): Blood pressure
Study 22292592 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 17323791 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17323791 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7805916 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 27993828 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 27993828 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 27993828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22910324 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20575654 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 28617566 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1